Immunotherapy is at the forefront of cancer care; however, most cancers evolve the ability to dodge the body’s defenses.
Maryland startup BeneVir is developing immunotherapy viruses that rid the body of two types of tumor cells – those that cause cancer and the ones that make it recurrent.
Funding and Research Opportunities
The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:
Notices:
Program Announcements
In 2015, hospitals will – and should – make more advanced use of “third platform” technologies based on mobile tools, social channels, data analytics and the cloud, according to a recent report from IDC Health Insights.
With healthcare costs unsustainable, but these new technologies now ubiquitous, IDC officials say hospital CIOs will increasingly be turning to new tools – especially as consumers expect healthcare to be as responsive to their wants and needs as other industries.
The color of your urine could be telling you something about your health condition. Yes, your standard yellow is where you want to be, but the different shades of the rainbow make an appearance on occasion.
Angel investors are often rich individuals who provide startups with capital for their start-up costs. The term comes from Broadway, where it was originally used to describe the wealthy individuals who provided money for theatrical productions.
Any small business or venture capital company interested in Small Business Innovation Research (SBIR) or Small Business Technology Transfer (STTR) funding opportunities should pay close attention to the Small Business Administration’s (SBA) recent request for public comments, by January 6, 2015, on data rights and Phase III funding, and a recent Government Accountability Office (GAO) report identifying the National Institutes of Health (NIH) and Department of Energy’s Advanced Research Projects Agency-Energy (ARPA-E) as the two agencies presently accepting applications from majority-owned portfolio companies.
Lacrosse sticks, construction models and surgical tools — these are all things Baltimore companies are making with the help of 3-D printing.
Three-dimensional printing was invented decades ago but has really taken off in the last few years. Printers are more affordable (you can get one for your desktop for the price of a MacBook Pro). And printing material has advanced significantly, to include more durable plastics, metal and more.
British drugmaker AstraZeneca plans to spend $200 million over the next three years, expanding its manufacturing facility in Frederick, Md., and hiring an additional 300 workers at the site, executives said.
The decision further cements Gaithersburg-based MedImmune, an AstraZeneca company, as the crown jewel of Maryland’s life sciences industry.
Nestled in a quiet industrial park in Redmond, Washington, not too far from the Microsoft headquarters, is a small biotech start-up with both an interesting technology they are bringing to market, as well as a capital partner that suggests some ways in which global biotech research, venture capital and commercialization are going to change.
The Federal Laboratory Consortium for Technology Transfer (FLC), a nationwide network of federal laboratories that cultivates best-practice strategies for advancing technology transfer (T2) from the laboratory to the marketplace, today announced the launch of FLCBusiness, an interactive business resource tool.
